More Affordable and Innovative Medicines and Treatments in Europe – Has the Competition Enforcement Met the 2009 Objective?

Published date19 March 2019
Law FirmOrrick, Herrington & Sutcliffe LLP
AuthorMarie-Laure Combet,Lena Boucon
Subject MatterCompetition,Life Sciences,EU,Cartels,Innovation,Prescription Drugs,Biosimilars,TFEU,Anti-Competitive,Antitrust Provisions,Regulatory Oversight,Merger Controls,Pharmaceutical Industry,Regulatory Requirements

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT